Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).

[1]  C. Reid,et al.  Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. , 2009, The Annals of thoracic surgery.

[2]  J. D. de Lemos,et al.  Clinical ResearchInterventional CardiologyA Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions: The SOS (Stenting Of Saphenous Vein Grafts) Trial , 2009 .

[3]  R. Erdim,et al.  Treatment of saphenous vein graft lesions with paclitaxel- and sirolimus-eluting stents: comparison of short- and long-term clinical outcomes. , 2008, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[4]  H. Gurm,et al.  Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis. , 2008, American heart journal.

[5]  M. Pfisterer,et al.  A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.

[6]  Pierfrancesco Agostoni,et al.  Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. , 2007, Journal of the American College of Cardiology.

[7]  Ralph D'Agostino,et al.  Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.

[8]  S. Pocock,et al.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.

[9]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[10]  N. Bruining,et al.  Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. , 2006, Journal of the American College of Cardiology.

[11]  Anthony A Bavry,et al.  Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. , 2006, The American journal of medicine.

[12]  N. Shafiq,et al.  A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease. , 2006, British journal of clinical pharmacology.

[13]  K. Kent,et al.  Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. , 2006, Journal of interventional cardiology.

[14]  Kurt Ulm,et al.  Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. , 2005, JAMA.

[15]  Deepak L. Bhatt,et al.  Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data). , 2005, The American journal of cardiology.

[16]  Deepak L. Bhatt,et al.  What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. , 2005, Journal of the American College of Cardiology.

[17]  Fernando Alfonso,et al.  Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. , 2005, Journal of the American College of Cardiology.

[18]  Robert J Anderson,et al.  Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. , 2004, Journal of the American College of Cardiology.

[19]  Thomas E. Moritz,et al.  Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery , 2004 .

[20]  J. M. Bloom.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. , 1998, The New England journal of medicine.

[21]  E. Topol,et al.  Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. , 1997, The American journal of cardiology.

[22]  J. O’Keefe,et al.  Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. , 1996, Journal of the American College of Cardiology.

[23]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[24]  M. Nobuyoshi,et al.  Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. , 1993, Journal of the American College of Cardiology.

[25]  F. Loop,et al.  Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. , 1985, The Journal of thoracic and cardiovascular surgery.